Literature DB >> 18076549

Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti.

Alexander Yaw Debrah1, Sabine Mand, Yeboah Marfo-Debrekyei, Linda Batsa, Kenneth Pfarr, Marcelle Buttner, Ohene Adjei, Dietrich Buttner, Achim Hoerauf.   

Abstract

OBJECTIVE: To evaluate the efficacy of doxycycline as a macrofilaricidal agent against Wuchereria bancrofti.
METHOD: In the Western Region of Ghana, 18 patients infected with W. bancrofti were recruited and treated with 200 mg doxycycline per day for 4 weeks. Seven untreated patients served as controls. Four months after doxycycline treatment, all patients received 150 mug/kg ivermectin. Patients were monitored for Wolbachia and microfilaria loads, antigenaemia and filarial dance sign (FDS).
RESULTS: Four months after doxycycline treatment, cases had a significantly lower Wolbachia load than controls; and 24 months after treatment, microfilaraemia, antigenaemia and frequency of FDS were significantly lower in cases than controls. Most importantly, 4 weeks of doxycycline killed 80% of macrofilariae, which is comparable with the results of a 6-week regimen. Circulating filarial antigenaemia and FDS were strongly correlated.
CONCLUSION: A 4-week regimen of doxycycline seems sufficient to kill adult W. bancrofti and could be advantageous for the treatment of individual patients, e.g. in outpatient clinics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18076549     DOI: 10.1111/j.1365-3156.2007.01949.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  32 in total

1.  Improved efficacy of tetracycline by acaciasides on Dirofilaria immitis.

Authors:  S Datta; S Maitra; P Gayen; S P Sinha Babu
Journal:  Parasitol Res       Date:  2009-05-09       Impact factor: 2.289

2.  Elevated levels of plasma angiogenic factors are associated with human lymphatic filarial infections.

Authors:  Sasisekhar Bennuru; Grace Maldarelli; V Kumaraswami; Amy D Klion; Thomas B Nutman
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

3.  Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus.

Authors:  Achim Hoerauf; Yeboah Marfo-Debrekyei; Marcelle Büttner; Alexander Yaw Debrah; Peter Konadu; Sabine Mand; Ohene Adjei; Dietrich W Büttner
Journal:  Parasitol Res       Date:  2008-04-18       Impact factor: 2.289

4.  Molecular evidence of curcumin-induced apoptosis in the filarial worm Setaria cervi.

Authors:  Ananya Nayak; Prajna Gayen; Prasanta Saini; Niladri Mukherjee; Santi P Sinha Babu
Journal:  Parasitol Res       Date:  2012-05-05       Impact factor: 2.289

5.  Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo.

Authors:  Andrea Schiefer; Alexander Schmitz; Till F Schäberle; Sabine Specht; Christine Lämmer; Kelly L Johnston; Dmitry G Vassylyev; Gabriele M König; Achim Hoerauf; Kenneth Pfarr
Journal:  J Infect Dis       Date:  2012-05-14       Impact factor: 5.226

6.  A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia.

Authors:  Laura R Serbus; Frederic Landmann; Walter M Bray; Pamela M White; Jordan Ruybal; R Scott Lokey; Alain Debec; William Sullivan
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

7.  Current evidence on the use of antifilarial agents in the management of bancroftian filariasis.

Authors:  Sumadhya Deepika Fernando; Chaturaka Rodrigo; Senaka Rajapakse
Journal:  J Trop Med       Date:  2010-12-30

8.  Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes.

Authors:  Kelly L Johnston; Bo Wu; Ana Guimarães; Louise Ford; Barton E Slatko; Mark J Taylor
Journal:  Parasit Vectors       Date:  2010-10-14       Impact factor: 3.876

Review 9.  Filariasis and lymphoedema.

Authors:  K M Pfarr; A Y Debrah; S Specht; A Hoerauf
Journal:  Parasite Immunol       Date:  2009-11       Impact factor: 2.280

10.  Characterization of transcription factors that regulate the type IV secretion system and riboflavin biosynthesis in Wolbachia of Brugia malayi.

Authors:  Zhiru Li; Clotilde K S Carlow
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.